Unit-Dose Parenteral Medication Preparation (Vials Ampules and Reconstitution)

Key Points

• Parenteral medications bypass gastrointestinal absorption and first-pass metabolism, supporting faster and more predictable systemic effect when oral use is unsuitable.
• Safe preparation requires strict sterility, correct diluent selection, and accurate dose/volume calculation.
• Single-dose vials are discarded after one use; ampules require filter-needle technique.
• During ampule withdrawal, do not inject air into the ampule and do not expel aspirated air bubbles back into the ampule.
• Reconstitution must follow manufacturer instructions for diluent type, volume, concentration, and storage.
• Reconstitution instructions must always be verified from authoritative labeling/eMAR resources and never assumed.
• Reconstitution math should be based on labeled post-reconstitution concentration for administration dose calculations; do not substitute dry-vial amount, diluent-only volume, or estimated displacement volume unless labeling explicitly directs that method.
• Mixing medications in one syringe requires confirmed compatibility and route-specific volume limits.
• Multi-dose vial handling requires open-date and beyond-use-date labeling (commonly up to 28 days unless manufacturer labeling requires earlier discard).
• Needle selection must match route/site/body composition and ordered volume; higher gauge numbers indicate smaller needle diameters.
• Syringe choice should match both target volume and graduation precision (for example smaller-volume syringes provide finer calibration marks).
• Route-specific common selections include finer gauges for ID/SQ and relatively lower gauges for many IM preparations, with individualized adjustment for very thin/cachectic patients.
• Prefilled cartridges/injector devices can improve speed, dose accuracy, and contamination control when product integrity and route instructions are verified.
• Prefilled syringe air-management follows product-specific rules; some products (for example enoxaparin prefilled syringes) require retaining the manufacturer air bubble.
• Hazardous/cytotoxic medication reconstitution requires containment controls, PPE, and pharmacy-trained handling workflows.
• Total mixed volume must stay within route/site and age-specific tolerance limits to avoid pain, poor absorption, and local adverse events.

Equipment

• MAR and active provider order access
• Ordered medication containers (single-dose vial, multidose vial, ampule, or prefilled cartridge)
• Sterile syringe/needle options (including Luer-lock or Luer-slip connectors, and fixed-needle formats such as insulin/tuberculin syringes) plus filter needle for ampule withdrawal
• Needleless/blunt vial-access devices when available for sharps-risk reduction
• Approved diluent and manufacturer/package instructions
• Alcohol swabs, gloves, sharps container, and labeling/documentation tools

Procedure Steps

1. Verify patient, order, route appropriateness (for example oral intolerance or need for non-oral onset profile), medication rights, concentration, expiration, and route-specific volume limits.
2. Perform hand hygiene and prepare a clean, low-interruption workspace.
3. Maintain injection-device sterility throughout setup: keep needles capped when not in use and avoid contaminating syringe plunger-shaft/Luer connection surfaces. Illustration reference: OpenStax Clinical Nursing Skills Ch.12.
4. Select syringe and needle size/connection style appropriate for solution characteristics and target volume (common syringe sizes span about 0.5-60 mL; many adult IV push doses are prepared in 3, 5, or 10 mL syringes). Needle gauge/length selection should reflect injection site, patient size/body composition, and dose volume; use Luer-lock when a secure twist-lock connection is needed and use Luer-slip/slip-tip formats when rapid attach/remove workflow is appropriate for the device context. After opening sterile packaging, handle the syringe by the barrel and keep tip/plunger sterile. Read syringe volume at the leading edge of plunger contact with solution, and match syringe size to required measurement precision (for example 1 mL syringes commonly marked by hundredths, 3 mL by tenths, many 5-12 mL by fifths/two-tenths, and large 60 mL syringes by whole-number marks). Illustration reference: OpenStax Clinical Nursing Skills Ch.12. Illustration reference: OpenStax Pharmacology Ch.2.3.
5. For vials, remove dust cover (not sterile), scrub diaphragm with 70% isopropyl alcohol, inject air as indicated (commonly matching planned withdrawal volume), keep needle tip within medication during draw-up, and withdraw exact volume with sterile technique.
6. If using multiple vials, use separate alcohol wipes per vial and maintain separate aseptic access events.
7. For multidose vials, label open date and beyond-use date per policy/manufacturer guidance (commonly up to 28 days unless manufacturer labeling specifies earlier disposal).
8. Keep multidose vials out of immediate patient-treatment areas unless policy requires point-of-care use with controlled handling.
9. For ampules, tap fluid down, cleanse neck, snap away from body with gauze or ampule breaker, and withdraw using a filter needle or filter blunt device; do not inject air into the ampule, and if air bubbles are aspirated, clear them in the syringe rather than expelling them back into the ampule.
10. Use medication withdrawn from ampules promptly and discard unused ampule medication per policy after the immediate preparation window.
11. Replace filter needle with administration-appropriate needle/device before giving medication.
12. If ampule break is irregular or glass shards are present in medication field, discard the ampule contents, clean glass safely, and restart with a new ampule.
13. Before calculation and draw-up, confirm the ordered dose and target final concentration from vial directions.
14. Verify reconstitution instructions from vial/insert/eMAR references (diluent type and volume, final concentration, storage conditions, and use-by timing) and never assume missing details.
15. For powdered drugs, reconstitute using the exact diluent and volume specified by manufacturer/pharmacy.
16. Mix as directed (gently rolling/swirl technique when indicated), confirm complete dissolution, verify final concentration, and confirm beyond-use/storage guidance.
17. When dose calculation is required after reconstitution, use the labeled post-reconstitution concentration (mg/mL) as the dose-conversion basis rather than dry-powder amount per vial alone.
18. For dual-compartment vial systems, activate the built-in diluent release per product design, gently swirl (do not shake), and verify no residual particles before withdrawal.
19. If combining medications in one syringe, confirm compatibility first (electronic database, institutional compatibility chart, or pharmacist consult) and keep total volume within route/site limits (for example ID ⇐ 0.5 mL, SQ usually ⇐ 1.5 mL, and IM limits adjusted by site/age).
20. When mixing medication from both vial and ampule, withdraw vial medication first, then use ampule-filter workflow, and finish with route-appropriate administration needle replacement.
21. For insulin mixing, follow ordered insulin-specific sequencing (clear before cloudy): commonly inject air into cloudy NPH first without withdrawing, then inject air into regular and withdraw regular first, then return to NPH to withdraw remaining dose to the ordered total; select an insulin syringe that can accurately measure the combined dose and never mix incompatible insulin types (for example glargine/detemir with other insulins). Illustration reference: OpenStax Clinical Nursing Skills Ch.12.
22. For prefilled syringes/cartridges, verify cartridge integrity, expiration, and volume against ordered dose; attach required plunger/needle component and manage air per product instructions (including retaining required air bubbles such as enoxaparin products when specified).
23. For reusable single-dose cartridge holders, disinfect holder surfaces between uses; if withdrawing medication from cartridge with needle/syringe, do not inject air into the cartridge system.
24. For auto-injector devices, confirm route/site suitability and follow product-specific activation sequence to deliver the preloaded single dose safely.
25. For hazardous/cytotoxic reconstitution, use required containment controls and PPE and defer compounding to trained pharmacy professionals per policy.
26. Prepare one medication syringe/device at a time; do not pre-label empty syringes.
27. Label prepared medication per policy unless prepared at bedside for immediate administration; when preparer and administrator differ, include diluent type/volume, diluent expiration, and medication use-by time.
28. Inspect final preparation for color/clarity/integrity changes and do not administer compromised products.
29. Complete medication-right verification checkpoints according to policy during preparation workflow (for example selection, preparation, and preadministration checks).
30. Dispose sharps immediately (including opened glass ampules in sharps container) and never reuse syringe/needle components.
31. Document preparation details, dose, route, and response plan.

Common Errors

• Reusing single-dose vials → contamination and infection risk.
• Withdrawing from ampule without filter needle → particulate contamination risk.
• Wrong diluent or wrong reconstitution volume → unsafe concentration and dose errors.
• Mixing incompatible medications or excess volume → precipitation/microparticle formation, altered potency, toxicity, or poor absorption risk.
• Using small/high-gauge needles for highly viscous medication withdrawal → bend/break and needlestick risk.
• Needle size mismatch for route/body habitus/volume → pain, bruising, incomplete delivery, or local tissue injury risk.
• Omitting multidose vial date/BUD labeling or treating vial dust caps as sterile → preventable contamination risk.
• Contaminating syringe plunger-shaft or Luer connection surfaces → syringe-content contamination and infection risk.
• Using medication from a chipped/shard-contaminated ampule → embolic, phlebitic, granulomatous, or inflammatory injury risk.
• Injecting air into ampules or pushing aspirated bubbles back into ampules → dosing contamination and glass-particulate exposure risk.
• Removing required prefilled-syringe air bubbles (for example enoxaparin products) → incomplete dose delivery risk.
• Injecting air into cartridge systems not designed for air injection → stopper expulsion and medication loss/injury risk.
• Reconstituting hazardous medications outside required containment/PPE workflow → occupational exposure risk.
• Exceeding route/site volume limits when mixing medications → pain, leakage, and unreliable absorption risk.
• Insulin sequencing errors or mixing incompatible long-acting insulin formulations → unstable glycemic response risk.
• Prelabeling empty syringes or leaving prepared syringes unattended → wrong-product/wrong-patient risk.
• Using dry-vial amount, diluent volume, or estimated final-volume displacement in place of labeled post-reconstitution concentration → wrong-dose calculation risk.

Related

• intradermal-medication-administration - ID-specific limits and technique constraints after preparation.
• subcutaneous-medication-administration - SQ route volume/angle requirements.
• intramuscular-medication-administration - IM site and volume decisions for prepared doses.
• intravenous-medication-administration-safety - IV compatibility and monitoring requirements.
• sharps-disposal-and-needlestick-response - Required sharps safety during preparation and administration.